Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s)sort descending Date Article Title Journal

Omar Abdel-Rahman

 November 2019 ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials International Journal of Colorectal Disease

Omar Abdel-Rahman

 August 2018 Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease Strahlentherapie und Onkologie

Omar Abdel-Rahman

 April 2018 Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials The Breast

Omar Abdel-Rahman

 September 2019 Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials The Breast Journal

Omar Abdel-Rahman

 June 2020 Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study The Clinical Respiratory Journal

Omar Abdel-Rahman

 October 2019 Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies Urologic Oncology: Seminars and Original Investigations

Omar Abdel‐Rahman, S. Ghosh, and J. Walker

 February 2020 Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials Clinical and Translational Oncology

Patrick M. Cotogno, Lahiru K. Ranasinghe, Elisa M. Ledet, Brian E. Lewis, Oliver Sartor

 April 2018 Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer The Oncologist

Paul Germonpré, Tim Van den Wyngaert and Conteporary Clinical Trials authors are: Louis Dron, Shirin Golchi, Grace Hsu, Kristian Thorlund

 April 2019 Second-Line Erlotinib After Failure of Pemetrexed-Containing Chemotherapy in Advanced non-Small Cell Lung Cancer (NSCLC): Real-World Effectiveness, Safety and Tolerability PLOS ONE

Qiyu Wang, Ian  A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J. Sullivan, Genevieve M. Boland, Kerry L. Reynolds, Meghan E. Sise

 August 2022 Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma ScienceDirect

Quentin Le Coënt, Catherine Legrand, Virginie Rondeau

 November 2022 Time-to-event surrogate endpoint validation using mediation analysis and meta-analytic data Biostatistics

Ran Zeng, Fang Liu, Chen Fang, Jin Yang, Lifeng Luo, Ping Yue, Beili Gao, Yuchao Dong, and Yi Xiang

 October 2021 PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients Frontiers in Immunology

Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Mei-Yin C Polley, Fahar Merchant, Lauren E Abrey, Joshua E Allen, Laura K Aguilar, Estuardo Aguilar-Cordova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Prof Timothy Cloughesy, Prof Patrick Y Wen, Brian M Alexander, Lorenzo Trippa

 September 2021 Leveraging external data in the design and analysis of clinical trials in neuro-oncology Lancet Oncology

Saki Nishiyama, Mamoru Narukawa

 February 2022 Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials The Oncologist

Pages